Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) EBT Margin (2024 - 2025)

Historic EBT Margin for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to 107118.75%.

  • Connect Biopharma Holdings' EBT Margin fell 1060671500.0% to 107118.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 6430.58%, marking a year-over-year change of. This contributed to the annual value of 59.17% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Connect Biopharma Holdings' EBT Margin is 107118.75%, which was down 1060671500.0% from 26758.33% recorded in Q2 2025.
  • Connect Biopharma Holdings' EBT Margin's 5-year high stood at 1051.6% during Q3 2024, with a 5-year trough of 107118.75% in Q3 2025.